KYPROLIS
Google image searchProduct monograph
Active ingredient
carfilzomib, 30 MG/VIAL
DIN: 02459949
Dosage form(s): POWDER FOR SOLUTION
Route(s) of administration: INTRAVENOUS
Description: FOR I.V. INFUSION. SINGLE-USE VIAL.
Schedule: Prescription
Company: AMGEN CANADA INC
Date: 06-FEB-2017
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XG — Proteasome inhibitors (ATC, ATC/DDD)
- L01XG02 — CARFILZOMIB (ATC/DDD)
Pharmaceutical standard: USP
